Using RNA therapeutics to promote healthy aging

Area of Science:

• Biogerontology
• Molecular Medicine
• RNA Therapeutics

Background:

• Aging is a natural process involving functional decline and increased disease risk.
• RNA therapeutics present a promising, targeted strategy for addressing aging mechanisms.
• These therapies offer advantages like specificity, low toxicity, and rapid production.

Purpose of the Study:

• To review recent advancements in RNA therapeutics for promoting healthy aging.
• To discuss the application of RNA technologies in treating age-related diseases.
• To explore the challenges and future potential of RNA-based interventions in aging.

Main Methods:

• Review of current literature on RNA therapeutics and aging research.
• Discussion of various RNA-based strategies: RNA activation, mRNA therapy, RNA interference, antisense oligonucleotides, aptamers, and CRISPR-Cas RNA editing.
• Analysis of preclinical and clinical studies for age-related conditions.

Main Results:

• RNA therapeutics encompass diverse modalities targeting aging at the molecular level.
• Promising preclinical and clinical data exist for neurodegenerative, cardiovascular, and musculoskeletal diseases.
• Key challenges include delivery, stability, and immunogenicity of RNA-based treatments.

Conclusions:

• The integration of RNA therapeutics with aging biology holds significant potential for developing novel anti-aging interventions.
• Further research and development are crucial to overcome current challenges and maximize efficacy.
• RNA technology is poised to revolutionize the treatment landscape for age-related diseases.